CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Kedrion: en ESID 2026, los expertos piden un diagnóstico más temprano de las inmunodeficiencias secundarias

ConferenceNeutral
AI Analysis

Summary

Kedrion presented at ESID 2026 conference on the need for earlier diagnosis of secondary immunodeficiencies, highlighting their clinical significance amid increased use of immunosuppressive and biologic therapies.

Importance:3/10
Sentiment:
0.00
immunodeficiencysecondary immunodeficienciesdiagnosisESID 2026conference

Read the original article

Published by PR Newswire Biotech on October 14, 2026 5:31 PM

Read Original